Wang Yundi, Zhao Hongjuan, Yan Hongli, Wang Yu
Reproductive Medicine Center, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
Reproductive Health Research Center of Inner Mongolia Autonomous Region, Hohhot, Inner Mongolia, China.
Intractable Rare Dis Res. 2025 Aug 31;14(3):183-191. doi: 10.5582/irdr.2025.01015.
Disorders of sex development (DSDs) encompass a spectrum of congenital conditions characterized by discordance among chromosomal, gonadal, and anatomical sex. Advances in genetic and molecular technologies have elucidated a complex landscape of underlying etiologies, including mutations in genes regulating sex determination and differentiation, copy number variations, and epigenetic alterations. These discoveries have not only enhanced diagnostic accuracy but also deepened our understanding of the molecular mechanisms driving DSDs. This review provides a comprehensive overview of the genetic architecture in DSDs, with a focus on key regulatory genes and their network interactions. We also highlight emerging concepts in the field, such as oligogenic inheritance and regulatory genomic elements, and discuss implications for personalized diagnosis, classification, and therapeutic strategies. By integrating recent advances from both clinical and basic research, this review aims to offer a framework for future investigations and translational applications in the management of DSDs.
性发育障碍(DSDs)涵盖一系列先天性疾病,其特征是染色体、性腺和解剖学性别之间不一致。遗传和分子技术的进步阐明了潜在病因的复杂情况,包括调节性别决定和分化的基因突变、拷贝数变异和表观遗传改变。这些发现不仅提高了诊断准确性,还加深了我们对驱动DSDs的分子机制的理解。本综述全面概述了DSDs的遗传结构,重点关注关键调控基因及其网络相互作用。我们还强调了该领域的新兴概念,如寡基因遗传和调控基因组元件,并讨论了其对个性化诊断、分类和治疗策略的影响。通过整合临床和基础研究的最新进展,本综述旨在为DSDs管理中的未来研究和转化应用提供一个框架。